Rheumatoid Arthritis N026
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/q-z/rheumatoid-arthritis-n026-m05m06
Rulebase for rheumatoid arthritis
<h5>Current RMA Instruments</h5><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2017/050.pdf" target="_blank">Reasonable Hypothesis</a></address></td><td>50 of 2017</td></tr><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2017/051.pdf" target="_blank">Balance of Probabilities</a></address></td><td>51 of 2017</td></tr></tbody></table><h5>Changes from previous Instruments</h5><p><drupal-media data-entity-type="media" data-entity-uuid="7b4b1f18-1581-44cb-884b-d7f3d73f63c1" data-view-mode="wysiwyg"></drupal-media></p><h5>ICD Coding:</h5><ul><li>ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81</li><li>ICD-10-AM Codes: M05, M06</li></ul><h5>Brief description</h5><p>Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.</p><h5><b>Confirming the diagnosis</b></h5><p>Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).</p><p>The relevant medical specialist is an rheumatologist.</p><h5>Additional diagnoses covered by SOP</h5><ul><li>Rheumatoid arthritis of the spine</li><li>Rheumatoid lung</li><li>Rheumatoid vasculitis</li><li>Felty’s syndrome</li></ul><h5>Conditions not covered by SOP</h5><ul><li>Rheumatic fever<sup><span lang="EN-GB">#</span></sup></li><li>Juvenile rheumatoid arthritis<sup><span lang="EN-GB">#</span></sup></li><li>Ankylosing spondylitis*</li><li>Non-rheumatoid inflammatory arthritis</li></ul><p>* another SOP applies</p><p><sup><span># </span></sup>non-SOP condition</p><h5>Clinical onset</h5><p>Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.</p><h5>Clinical worsening</h5><p>The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.</p><p> </p>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rulebase-rheumatoid-arthritis
Cigar smoking
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/cigar-smoking
Cigarette smoking
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/cigarette-smoking
Exposure to mineral oil
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/exposure-mineral-oil
Inability to obtain appropriate clinical management for rheumatoid arthritis
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/inability-obtain-appropriate-clinical-management-rheumatoid-arthritis
Inhaling respirable crystalline silica dust
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/inhaling-respirable-crystalline-silica-dust
Pipe smoking
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/pipe-smoking
Smoking tobacco products - material contribution
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/smoking-tobacco-products-material-contribution
Treatment with a drug that aggravates rheumatoid arthritis
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/treatment-drug-aggravates-rheumatoid-arthritis
Treatment with a drug that causes rheumatoid arthritis
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/treatment-drug-causes-rheumatoid-arthritis
Treatment with the drug interferon-alpha
Current RMA Instruments
| Reasonable Hypothesis | 50 of 2017 |
| Balance of Probabilities | 51 of 2017 |
Changes from previous Instruments
ICD Coding:
- ICD-9-CM Codes: 714.0, 714.1, 714.2, 714.81
- ICD-10-AM Codes: M05, M06
Brief description
Rheumatoid arthritis is a chronic symmetric, inflammatory, peripheral polyarthritis. It can lead to joint deformity and destruction if not sucessfully treated. Associated features outside of the joints, affecting a wide range of organs and tissues occur in about 40% of cases over the lifetime of the disease.
Confirming the diagnosis
Diagnosis is difficult, particularly in the early stages of disease. Distinctive features and extrarticular manifestations are generally absent until later stages. There is no single test or clinical feature that is diagnostic. Diagnosis is based on the clinical findings (including duration of symptoms), serology and other blood test results, and exclusion of diseases with similar clinical features (including psoriatic arthritis, acute viral polyarthritis, polyarticular gout and systemic lupus erythematosus).
The relevant medical specialist is an rheumatologist.
Additional diagnoses covered by SOP
- Rheumatoid arthritis of the spine
- Rheumatoid lung
- Rheumatoid vasculitis
- Felty’s syndrome
Conditions not covered by SOP
- Rheumatic fever#
- Juvenile rheumatoid arthritis#
- Ankylosing spondylitis*
- Non-rheumatoid inflammatory arthritis
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when symptoms of peripheral arthritis in multiple joints, subsequently diagnosed as rheumatoid arthritis, first developed.
Clinical worsening
The course of the disease and the response to treatment are variable. Good control or remission early in the disease process is the aim of therapy. An inability to obtain a timely diagnosis and appropriate specialist care may be a potential cause of clinical worsening for this disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/treatment-drug-interferon-alpha